Roboz, Gail J.Sanz, GuillermoGriffiths, Elizabeth A.Yee, KarenKantarjian, HagopRécher, ChristianByrne, Michael T.Patkowska, ElżbietaKim, Hee-JeThomas, XavierMoors, IneStock, WendyIllés, ÁrpádFenaux, PierreMiyazaki, YasushiYamauchi, TakahiroO'Connell, Casey L.Hao, YongKeer, Harold N.Azab, MohammadDöhner, Hartmut2024-07-242024-07-242024Blood Advances. -8 : 8 (2024), p. 2020-2029. -Blood Adv. - 2473-9529. - 2473-95372473-95372473-9529https://hdl.handle.net/2437/377057folyóiratcikkopen access articlehttps://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM122910OrvostudományokKlinikai orvostudományokhttps://ashpublications.org/bloodadvances/article/8/8/2020/514602/Guadecitabine-vs-TC-in-relapsed-refractory-AMLThe American Society of Hematologyhttp://dx.doi.org/10.1182/bloodadvances.20230120622024-07-2400123528730000185191585888